Cargando…

Society for Immunotherapy of Cancer clinical and biomarkers data sharing resource document: Volume II—practical challenges

The development of strongly predictive validated biomarkers is essential for the field of immuno-oncology (IO) to advance. The highly complex, multifactorial data sets required to develop these biomarkers necessitate effective, responsible data-sharing efforts in order to maximize the scientific kno...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cesano, Alessandra, Cannarile, Michael A, Gnjatic, Sacha, Gomes, Bruno, Guinney, Justin, Karanikas, Vaios, Karkada, Mohan, Kirkwood, John M, Kotlan, Beatrix, Masucci, Giuseppe V, Meeusen, Els, Monette, Anne, Naing, Aung, Thorsson, Vésteinn, Tschernia, Nicholas, Wang, Ena, Wells, Daniel K, Wyant, Timothy L, Rutella, Sergio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2020
Materias:	Position Article and Guidelines
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7745522/ https://www.ncbi.nlm.nih.gov/pubmed/33323463 http://dx.doi.org/10.1136/jitc-2020-001472

Ejemplares similares

Society for Immunotherapy of Cancer clinical and biomarkers data sharing resource document: Volume I—conceptual challenges
por: Rutella, Sergio, et al.
Publicado: (2020)

Strategies for improving the management of immune-related adverse events
por: Naing, Aung, et al.
Publicado: (2020)

The Society for Immunotherapy in Cancer statement on best practices for multiplex immunohistochemistry (IHC) and immunofluorescence (IF) staining and validation
por: Taube, Janis M, et al.
Publicado: (2020)

Trial Reporting in Immuno-Oncology (TRIO): an American society of clinical oncology-society for immunotherapy of cancer statement
por: Tsimberidou, Apostolia M., et al.
Publicado: (2018)

An update on the Society for Immunotherapy of Cancer consensus statement on tumor immunotherapy for the treatment of cutaneous melanoma: version 2.0
por: Sullivan, Ryan J., et al.
Publicado: (2018)

Diagnostic tools in Rhinology EAACI position paper
por: Scadding, Glenis, et al.
Publicado: (2011)

Hemoglobin A1c measurement for the diagnosis of Type 2 diabetes in children
por: Kapadia, Chirag, et al.
Publicado: (2012)

The biodiversity hypothesis and allergic disease: world allergy organization position statement
por: Haahtela, Tari, et al.
Publicado: (2013)

Predictive, Preventive and Personalised Medicine as the hardcore of ‘Horizon 2020’: EPMA position paper
por: Golubnitschaja, Olga, et al.
Publicado: (2014)

Towards personal health care with model-guided medicine: long-term PPPM-related strategies and realisation opportunities within ‘Horizon 2020’
por: Lemke, Heinz U, et al.
Publicado: (2014)

Canadian hereditary angioedema guideline
por: Betschel, Stephen, et al.
Publicado: (2014)

EAACI: A European Declaration on Immunotherapy. Designing the future of allergen specific immunotherapy
por: Calderon, Moises A, et al.
Publicado: (2012)

Research needs in allergy: an EAACI position paper, in collaboration with EFA
por: Papadopoulos, Nikolaos G, et al.
Publicado: (2012)

Fungal allergy in asthma–state of the art and research needs
por: Denning, David W, et al.
Publicado: (2014)

EPMA summit 2014 under the auspices of the presidency of Italy in the EU: professional statements
por: Golubnitschaja, Olga, et al.
Publicado: (2015)

EPMA position paper in cancer: current overview and future perspectives
por: Grech, Godfrey, et al.
Publicado: (2015)

Dietary exposures and allergy prevention in high-risk infants: a joint position statement of the Canadian Society of Allergy and Clinical Immunology and the Canadian Paediatric Society
por: Chan, Edmond S, et al.
Publicado: (2014)

Predicting formation of adhesions after gynaecological surgery: development of a risk score
por: Lundorff, Per, et al.
Publicado: (2015)

World Allergy Organization-McMaster University Guidelines for Allergic Disease Prevention (GLAD-P): Prebiotics
por: Cuello-Garcia, Carlos A., et al.
Publicado: (2016)

World Allergy Organization-McMaster University Guidelines for Allergic Disease Prevention (GLAD-P): Vitamin D
por: Yepes-Nuñez, Juan José, et al.
Publicado: (2016)

Consensus communication on early peanut introduction and the prevention of peanut allergy in high-risk infants
por: Fleischer, David M., et al.
Publicado: (2015)

World Allergy Organization-McMaster University Guidelines for Allergic Disease Prevention (GLAD-P): Probiotics
por: Fiocchi, Alessandro, et al.
Publicado: (2015)

CSACI position statement: systemic effect of inhaled corticosteroids on adrenal suppression in the management of pediatric asthma
por: Issa-El-Khoury, Karine, et al.
Publicado: (2015)

Allergen immunotherapy on the way to product-based evaluation—a WAO statement
por: Bachert, Claus, et al.
Publicado: (2015)

2015 update of the evidence base: World Allergy Organization anaphylaxis guidelines
por: Simons, F. Estelle R., et al.
Publicado: (2015)

Expert consensus on standardized diagnosis and treatment for heat stroke
Publicado: (2016)

Addendum guidelines for the prevention of peanut allergy in the United States: report of the National Institute of Allergy and Infectious Diseases-sponsored expert panel
por: Togias, Alkis, et al.
Publicado: (2017)

Addendum guidelines for the prevention of peanut allergy in the United States: Report of the National Institute of Allergy and Infectious Diseases–sponsored expert panel
por: Togias, Alkis, et al.
Publicado: (2017)

Manifesto on small airway involvement and management in asthma and chronic obstructive pulmonary disease: an Interasma (Global Asthma Association - GAA) and World Allergy Organization (WAO) document endorsed by Allergic Rhinitis and its Impact on Asthma (ARIA) and Global Allergy and Asthma European Network (GA(2)LEN)
por: Braido, F., et al.
Publicado: (2016)

Manifesto on small airway involvement and management in asthma and chronic obstructive pulmonary disease: an Interasma (Global Asthma Association - GAA) and World Allergy Organization (WAO) document endorsed by Allergic Rhinitis and its Impact on Asthma (ARIA) and Global Allergy and Asthma European Network (GA(2)LEN)
por: Braido, F., et al.
Publicado: (2019)

Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of renal cell carcinoma
por: Rini, Brian I., et al.
Publicado: (2016)

The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of hematologic malignancies: multiple myeloma, lymphoma, and acute leukemia
por: Boyiadzis, Michael, et al.
Publicado: (2016)

The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of prostate carcinoma
por: McNeel, Douglas G., et al.
Publicado: (2016)

Metabolic diagnosis and medical prevention of calcium nephrolithiasis and its systemic manifestations: a consensus statement
por: Gambaro, Giovanni, et al.
Publicado: (2016)

Practical recommendations for fertility preservation in women by the FertiPROTEKT network. Part II: fertility preservation techniques
por: von Wolff, Michael, et al.
Publicado: (2017)

Practical recommendations for fertility preservation in women by the FertiPROTEKT network. Part I: Indications for fertility preservation
por: Schüring, A. N., et al.
Publicado: (2017)

Expert consensus on the evaluation and diagnosis of combat injuries of the Chinese People’s Liberation Army
por: Zong, Zhao-wen, et al.
Publicado: (2018)

Chinese expert consensus on echelons treatment of pelvic fractures in modern war
por: Zong, Zhao-wen, et al.
Publicado: (2018)

Nutritional treatment of advanced CKD: twenty consensus statements
por: Cupisti, Adamasco, et al.
Publicado: (2018)

The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of non-small cell lung cancer (NSCLC)
por: Brahmer, Julie R., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_fkvedqvdtea66g067bvthln0ef